Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Fluocinolone Acetonide Tincture, often marketed under brand names like Piyanping Ding, is a topical combination drug used for various skin conditions. Its active ingredients include fluocinolone acetonide, salicylic acid, and borneol. Fluocinolone acetonide is a potent corticosteroid that provides anti-inflammatory and anti-allergic effects by constricting blood vessels, reducing capillary permeability, and alleviating symptoms such as redness, swelling, and pain. Salicylic acid acts as a keratolytic agent, helping to shed dead skin cells, and also possesses antifungal properties. Borneol contributes analgesic, antibacterial, and antipruritic (anti-itch) effects, aiding in desquamation and itch relief. This combination is primarily indicated for neurodermatitis, particularly the lichenified type, and also shows efficacy in treating psoriasis and general pruritus. It is applied topically to the affected skin area.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Compound Fluocinolone Acetonide Tincture.